Recent Posts
Deals•Feb 20, 2026
Arlington Scientific Completes Acquisition of Awareness Technology's ELISA Product Line
Arlington Scientific announced the completion of its acquisition of the EIA/ELISA product line from Awareness Technology, expanding its portfolio in immunoassay technologies. Financial terms were not disclosed.
CAP Today
News•Feb 17, 2026
Illumina Gets CMS Reimbursement for TSO Comprehensive
Illumina announced that the Centers for Medicare & Medicaid Services (CMS) has granted reimbursement for its FDA‑approved TruSight Oncology Comprehensive (TSO Comprehensive) test. The decision enables Medicare coverage of the in‑vitro diagnostic, which profiles hundreds of cancer‑related genes. This marks...
By CAP Today
News•Feb 17, 2026
Volta Labs Adds WGS Apps to Callisto Platform
Volta Labs has expanded its Callisto sample‑preparation platform by integrating seven validated whole‑genome sequencing (WGS) DNA applications. The new apps turn Callisto into an end‑to‑end solution capable of handling extraction, fragmentation, and library construction for high‑throughput WGS workflows. By embedding...
By CAP Today
News•Feb 17, 2026
From the President’s Desk
In his February 2026 presidential column, Dr. Qihui‑Jim Zhai urges the pathology community to embrace digital pathology and AI tools rather than wait for perfect solutions. He argues that resistance risks being left behind as laboratories worldwide adopt these technologies to...
By CAP Today
Deals•Feb 17, 2026
Natera Acquires Cancer Diagnostics Firm Foresight Diagnostics
Natera announced the completion of its acquisition of Foresight Diagnostics, a company specializing in cancer diagnostics. The deal expands Natera's oncology testing portfolio. Financial terms were not disclosed.
CAP Today